Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pooling real-world multiple sclerosis patient data on a European level: a true story of success.
Stem cell therapy for central nerve system injuries: glial cells hold the key.
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
Methods and measures: what's new for MS?
Oral laquinimod for multiple sclerosis.
CNS diseases and uveitis.
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
CCR2+CCR5+ T Cells Producing Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis.
Multiple sclerosis and oral health--an update.
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
[Differential diagnosis between multiple sclerosis and neurological presentations of HIV-infection: a literature review and a case report].
Physician-patient communication skills: e-tools.
Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996-2008.
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
Clinical application of susceptibility weighted imaging: exploring from routine service.
Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Structural connectomics in brain diseases.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Deafness in Patients with Multiple Sclerosis.

Pages